Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly vs Two Doses of SP for Malaria Prevention in Pregnancy
NCT03599596Phase 1Unknown
- Sponsor
- University College Hospital, Ibadan
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by University College Hospital, Ibadan. Primary endpoint: Level of malaria parasitemia at 4 months. Status: unknown.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03599596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03599596.